Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis

PURPOSE: To assess the efficacy and safety of aripiprazole once-monthly 400 mg (AOM 400), an extended-release injectable suspension of aripiprazole, in obese and nonobese patients. PATIENTS AND METHODS: This post hoc analysis of a 38-week randomized, double-blind, active-controlled, noninferiority s...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuropsychiatr Dis Treat
Autori principali: De Hert, Marc, Eramo, Anna, Landsberg, Wally, Kostic, Dusan, Tsai, Lan-Feng, Baker, Ross A
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2015
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4455850/
https://ncbi.nlm.nih.gov/pubmed/26064048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S80479
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi